Come and visit us at the 8th Annual Meeting of the German Society of Nephrology in Berlin from 10th-13th September 2016.
The world’s largest event for the medical sector in the field of dialysis.Read more
The 16th Asian Pacific Congress of Nephrology & 2018 Annual Congress of Chinese Society of Nephrology is being held by the Chinese Society of Nephrology from 29th-31st March 2018 at the China National Convention Center, Beijing.Read more
The 48th Annual Congress of the Indian Society of Nephrology, “ISNCON 2017”, is being held from 14-17th December 2017 at the Pullman-Novotel Hotel Aerocity, in New Delhi.Read more
Both companies will primarily act as local premises for D.Med’s technical service business unit.
Nipro presented its latest products in the dialysis field and impressed with a booth in the traditional Vienna coffee house style.
D.Med Healthcare GmbH & Co. KG and Changshan Pharmaceutical (Hongkong) Co. Ltd., 100% subsidiary of the stock-listed Chinese manufacturer of pharmaceutical products, Hebei Changshan Biomedical Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange / SIN 300255:CH), announce the set-up of a joint venture aiming at the production and marketing of Heparin formulations
In order to strengthen its role in the production, sales, marketing and further development of the highly innovative Gynedil dilation devices (www.gynedil.com), D.Med Healthcare AG has increased its share in Belgrade-based Inove d.o.o., the manufacturer of Gynedil, from 10 to 54.5% by taking over the shares of the company’s founder Dobrivoje Rajkovic. This deal underlines the importance of the Gynaecology segment in D.Med’s future strategy and will be followed by further steps in this field.
In the course of our expansion strategy in Africa we gladly announce the opening of new D.Med Healthcare sales entities in Kenya, Mozambique and Zimbabwe which will enable us to be even closer to our regional customers and partners and open up new opportunities in these buzzing markets.